Safety and Efficiency of Transplantation of Allogenic Multipotent Stromal Cells in Surgical Treatment of Dilatated Cardiomyopathy

[1]  S. Dimmeler,et al.  Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis , 2008, Fibrogenesis & tissue repair.

[2]  Lawrence Buja,et al.  Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. , 2008, Journal of molecular and cellular cardiology.

[3]  Jian-an Wang,et al.  Brain natriuretic peptide: A potential indicator of cardiomyogenesis after autologous mesenchymal stem cell transplantation? , 2006, Journal of Zhejiang University SCIENCE B.

[4]  T. Olson.  What makes the heart fail? New insights from defective genes. , 2006, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[5]  Henry Krum,et al.  The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). , 2005, European heart journal.

[6]  Frank P Barry,et al.  Mesenchymal stem cells avoid allogeneic rejection , 2005, Journal of Inflammation.

[7]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[8]  B. Fleischmann,et al.  Searching for reputability: first randomised study on bone-marrow transplantation in the heart , 2004, The Lancet.

[9]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.